Lurasidone for the Treatment of Schizophrenia: Design, Development, and Place in Therapy
Itaru Miura,1 Sho Horikoshi,1,2 Mizue Ichinose,1,3 Yuhei Suzuki,1 Kenya Watanabe4 1Department of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima, Japan; 2Department of Neuropsychiatry, Horikoshi Psychosomatic Clinic, Fukushima, Japan; 3Department of Neuropsychiatry, Hoshi...
Main Authors: | Miura I, Horikoshi S, Ichinose M, Suzuki Y, Watanabe K |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-09-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/lurasidone-for-the-treatment-of-schizophrenia-design-development-and-p-peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Real-world treatment patterns and outcomes in patients initiating lurasidone for the treatment of schizophrenia in Europe
by: A. Jones, et al.
Published: (2022-06-01) -
Schizophrenia relapse, patient considerations, and potential role of lurasidone
by: Citrome L
Published: (2016-08-01) -
Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia
by: Afzal Javed, et al.
Published: (2019-05-01) -
The Role of Lurasidone in Managing Depressive Symptoms in People with Schizophrenia: A Review
by: Andrea Fiorillo, et al.
Published: (2024-02-01) -
Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study
by: Iyo M, et al.
Published: (2021-08-01)